Rocket Doctor AI

AIDR

The current Rocket Doctor AI (AIDR) market capitalization is approximately CA$68.79M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Rocket Doctor AI's market cap fluctuates with changes in its share price and share count. Last updated: February 15, 2026 at 5:20 PM Eastern Time

In the most recently reported quarter, Rocket Doctor AI (AIDR) generated CA$38.14K in revenue. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: February 15, 2026 at 4:27 AM Eastern Time

In the most recently reported quarter, Rocket Doctor AI (AIDR) revenue was CA$38.14K. Earnings per share (EPS) for the quarter were CA$-0.12. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: February 15, 2026 at 4:27 AM Eastern Time

Rocket Doctor AI (AIDR) does not currently pay a dividend. Over the last twelve months (LTM), the company paid CA$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: February 15, 2026 at 4:27 AM Eastern Time

Analyst assessments of whether Rocket Doctor AI (AIDR) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: CA$0.73Consensus price target: CA$2.10Implied return: +187.67% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: February 15, 2026 at 4:27 AM Eastern Time

Based on the latest available analyst coverage, Rocket Doctor AI (AIDR) currently carries a Buy consensus rating. Analysts' average AIDR price target is CA$2.10. Relative to the current share price of CA$0.73, this suggests a potential price change of approximately +187.67%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: February 15, 2026 at 4:27 AM Eastern Time

Like other publicly traded stocks, Rocket Doctor AI (AIDR) shares are bought and sold on stock exchanges such as CNSX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Rocket Doctor AI (AIDR) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add AIDR to your watchlist.

Rocket Doctor AI trades under the ticker symbol AIDR on the CNSX stock exchange. The ticker AIDR is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Rocket Doctor AI (AIDR) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Rocket Doctor AI (AIDR) stock peers based on overlapping products, services, and competitive dynamics:DIAGNOS (ADK)Artrya (AYA)NetraMark Holdings (AIAI)Aclarion (ACON)CodeLab Capital AS (CODE)CardioComm Solutions (EKG)Seegnal (SEGN)Vitalhub (VHI)Must Capital (MUST.H) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Rocket Doctor AI.